Inventor · disambiguated record
Jeremy Loyau
Also filed as: LOYAU JEREMY · LOYAU JÉRÉMY
8 granted patents·5 pending applications·6 citations·filing 2013–2025
79Inventor score
Top patents by PatentIndex Score
13 records- 0190US11970539B2Antibodies that bind to IL1RAP and uses thereofIchnos Sciences SA·Filed 2021·Granted Apr 30, 2024·4 cites·11 claims
- 0279US12492260B2Antibodies that bind to IL1RAP and uses thereofIGI Therapeutics SA·Filed 2024·Granted Dec 9, 2025·0 cites·7 claims
- 0379US12492259B2Antibodies that bind to IL1RAP and uses thereofIGI Therapeutics SA·Filed 2024·Granted Dec 9, 2025·0 cites·7 claims
- 0474US10400044B2Anti-TLR4 antibodies and uses thereofNOVIMMUNE SA·Filed 2016·Granted Sep 3, 2019·1 cites·17 claims
- 0574US2022324994A1Anti-tlr4 antibodies and uses thereofNOVIMMUNE SA·Filed 2021·Application pending·0 cites
- 0673US2025361310A1Antibodies that bind to il1rap and uses thereofIGI Therapeutics SA·Filed 2025·Application pending·0 cites
- 0772US9453076B2Anti-TLR4 antibodies and uses thereofNOVIMMUNE SA·Filed 2013·Granted Sep 27, 2016·1 cites·13 claims
- 0870US10982004B2Anti-TLR4 antibodies and uses thereofNOVIMMUNE SA·Filed 2019·Granted Apr 20, 2021·0 cites·11 claims
- 0958US12338292B2CD47-CD38 bispecific antibodiesIGI Therapeutics SA·Filed 2021·Granted Jun 24, 2025·0 cites·12 claims
- 1057US2024228650A9CD3/BCMA/CD38 Trispecific AntibodiesIchnos Sciences SA·Filed 2023·Application pending·0 cites
- 1156US2024150489A1Cd47-cd38 bispecific antibodiesIchnos Sciences SA·Filed 2023·Application pending·0 cites
- 1255US2024141062A1Cd47-cd38 bispecific antibodiesIchnos Sciences SA·Filed 2023·Application pending·0 cites
- 1338US10640564B2Antibodies that bind to CCR6 and their usesIchnos Sciences SA·Filed 2015·Granted May 5, 2020·0 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when Jeremy Loyau files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →